Following the acquisition of Arrow Generics by Watson in December 2009, what complementarities and synergies were generated from the transaction and where do you stand today…
In Conversation
Rather than Mr. Bugarin’s personal views, the following information contains general statements provided by the Serbian Chamber of Commerce Current trends in pharmaceutical industry The production…
To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have…
As a Taiwanese national and Country Head of Novartis Taiwan, what is your opinion on the current state of the pharmaceutical industry in Taiwan, and what…
Giddi Pharma was founded in 1995. What was the vision behind the creation of the company? What founding principles did you have when you founded Giddi?…
Priorities and plans of the Ministry of Health If we entered an election year with a major reform plan, we would not succeed in putting such…
Within a broad assessment of Romania’s investment climate, there is no doubt that every country has some key factors upon which can be capitalized to attract…
You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our readers an idea on how the market…
You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo,…
You have only just arrived from Korea to head the Romanian operations at MSD. Just recently, you told in an interview with Medica Academica that MSD…
2010 is ScinoPharm’s thirteenth year of operations. Thirteen does not seem to be an unlucky number for you as your company is doing particularly well at…
